September 7, 2016: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Presentations
FDA Presentations
- Gene Transfer and Immunogenicity Branch Presentation - Dr. Byrnes
Andrew Byrnes, PhD, Principal Investigator, Branch Chief - Dr. Puri's OCTGT Overview
Dr. Raj K. Puri, Ph.D., M.D, Director, Division of Cellular and Gene Therapies - Dr. Wilson's CBER and FDA Overview
Carolyn A. Wilson, Ph.D., Associate Director for Research